Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Paula Tanabe, RN, PhD
Researcher Laurel Chadwick Distinguished Professor
Duke University School of Nursing
307 Trent Drive
Durham, North Carolina, United States
Paula Tanabe, PhD, RN, MPH, FAEN, FAAN, is a Professor in the Schools of Nursing and Medicine and health services and clinical researcher. Dr. Tanabe’s program of research focuses on improving systems of healthcare and patient outcomes for persons with sickle cell disease. Dr. Tanabe has a strong focus on improving emergency department care for this population and has conducted many investigations in this area.
Dr. Tanabe currently has AHRQ funding to disseminate decision support tools to primary care and emergency department providers throughout North Carolina and portions of South Carolina. These tools were based upon the National Heart, Lung and Blood Institute evidence-based recommendations for the treatment of sickle cell disease. Dr. Tanabe is also the co-PI for the National Heart, Lung and Blood Institute “Sickle Cell Disease Implementation Consortium, U01”.
Dr. Tanabe has conducted investigations aimed at improving pain management in the emergency department, with a strong focus on patients with sickle cell disease. Dr. Tanabe developed the Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a decision support tool aimed at improving the quality of care provided to adults with sickle cell disease in the ED setting.
+myBinderRelated Content
-
NYC Health + HospitalsNYC Health + Hospitals are the largest p...
-
Bryan B. Bushman, PhDBryan Bushman, Ph.D., is a licensed clin...
-
Steven Ambrusko, MD, MSDr. Ambrusko is a pediatric hematologist...
-
Risk Factors for 30-Day Readmission in Adults with Sickle Cell DiseaseBACKGROUND: Readmission to the hospital...
-
Sensorineural Hearing Loss in Children With Sickle Cell DiseaseIntroduction: Sensorineural hearing los...
-
Debunking the Myths About Sickle Cell Diseasehttps://www.youtube.com/watch?v=OZMwkE-W...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
